PROQR THERAPEUTICS NV (PRQR) Stock Income Statement
NASDAQ:PRQR - Nasdaq - NL0010872495 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.55M | 9.53M | 4.80M | 2.40M | 9.45M | |||
| Minority Interest Expense | 0.00 | -384.00K | -220.00K | 60.00K | 50.00K | |||
| Operating Expenses | 50.02M | 41.38M | 69.52M | 59.59M | 51.82M | |||
| Research and Development | 34.02M | 23.15M | 48.78M | 40.53M | 36.35M | |||
| Selling, General, and Administrative Expenses | 13.23M | 15.72M | 18.22M | 16.73M | 13.12M | |||
| Operating Income | -30.47M | -31.86M | -64.72M | -57.19M | -42.37M | |||
| Interest Income/Expense | 2.51M | 2.09M | 1.31M | -4.37M | -4.12M | |||
| Other Income/Expense | 0.00 | 0.00 | N/A | 510.00K | N/A | |||
| Non Recurring Items | 0.00 | 1.87M | -1.39M | N/A | N/A | |||
| Income Before Taxes | -27.96M | -27.81M | -64.80M | -61.56M | -46.49M | |||
| Income Tax | -197.00K | -78.00K | 100.00K | 120.00K | 120.00K | |||
| Net Income | -27.76M | -28.12M | -65.11M | -61.62M | -46.57M | |||
| EBITDA | -27.71M | -29.35M | -62.20M | -54.86M | -40.01M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.32 | -0.35 | -0.91 | -0.96 | -0.93 | |||
| Non GAAP EPS | -0.31 | -0.35 | -0.91 | -0.97 | -0.92 | |||
| Statistics | ||||||||
| Profit Margin | -142.05% | -295.21% | -1356.46% | -2567.50% | -492.80% | |||
| Operating Profit Margin | -155.91% | -334.48% | -1348.33% | -2382.92% | -448.36% | |||
All data in EUR